Funding for this research was provided by:
Ministerio de Economía y Competitividad (BES-2015-075576, PSI2017-84764-P)
Received: 6 August 2019
Accepted: 22 November 2019
First Online: 27 December 2019
Ethics approval and consent to participate
: The European Union Agency for Fundamental Rights supervised and approved the secondary data analyses conducted in this study, as well as the study design, granting a special license for this purpose (reference number 102577). Informed consent from all participants was obtained verbally by the interviewers of the European Union Agency for Fundamental Rights. The reason for not collecting written consent was to ensure that respondents would not be put in danger by having any written documents which associate the name of the respondent and their participation in the survey. It was also important that interviewers would not leave any material behind which could potentially jeopardize the safety of the respondents, such as copies of consent forms that disclose the name of the survey.
: Patient consent detail was removed from this study to ensure anonymity. The data set provided by the European Union Agency for Fundamental Rights did not contain personal information about the women who agreed to be interviewed.
: The authors declare that they have no competing interests.